Butabarbital decreases outcomes of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Coadministration of CYP3A4 inducers may well decrease sufentanil amounts and efficacy, quite possibly precipitating withdrawal syndrome in individuals that have created physical dependence to sufentanil. Discontinuation of concomitantly ... https://haynesm775qtu7.bleepblogs.com/profile